Loading company…
Presidio Pharmaceuticals discovers and develops small-molecule antiviral drugs.
Presidio Pharmaceuticals is a clinical-stage company focused on discovering and developing small-molecule antiviral therapeutics. Founded in 2006, the company is based in San Francisco, US, and is at the Series D stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in